Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Manal F. Abdelmalek"'
Autor:
Manal F. Abdelmalek, Ayako Suzuki, Willian Sanchez, Eric Lawitz, Claudia Filozof, Hyungjin Cho, Eunhye Baek, JaeDuk Choi, Seungjae Baek
Publikováno v:
Contemporary Clinical Trials. 130:107176
Autor:
Atsushi Nakajima, Arun J. Sanyal, Johanna R Mora, Brent A. Neuschwander-Tetri, Edgar D. Charles, Rohit Loomba, Stephen A. Harrison, Giridhar S. Tirucherai, Diane E. Shevell, Shuyan Du, Zachary Goodman, George H. Klinger, Masayuki Yamaguchi, Richard A. Ehman, Morten A. Karsdal, Manal F. Abdelmalek
Publikováno v:
Contemporary clinical trials. 104
Background Nonalcoholic steatohepatitis (NASH) is the progressive form of nonalcoholic fatty liver disease (NAFLD); no approved therapies for NASH currently exist. Pegbelfermin (PGBF), a human fibroblast growth factor 21 analog, has metabolic effects
Autor:
Brent A. Neuschwander-Tetri, Maria Lucia Pecoraro, Zobair M. Younossi, Arun J. Sanyal, Star Seyedkazemi, Vincent Wai-Sun Wong, Manal F. Abdelmalek, Pierre Bedossa, Naim Alkhouri, Jiacheng Yuan, Laurent Fischer, Quentin M. Anstee, Zachary Goodman, Frank Tacke
Publikováno v:
Contemporary clinical trials. 89
Introduction Nonalcoholic steatohepatitis (NASH) is a sub-classification of nonalcoholic fatty liver disease (NAFLD) characterized by increased risk of progressive liver fibrosis. Cenicriviroc (CVC) is a novel, orally administered, potent chemokine 2
Autor:
Sven M., Francque1,2 (AUTHOR) Sven.Francque@uza.be, Pierre, Bedossa3,4 (AUTHOR), Manal F., Abdelmalek5 (AUTHOR), Quentin M., Anstee4,6,7 (AUTHOR), Elisabetta, Bugianesi8 (AUTHOR), Vlad, Ratziu9 (AUTHOR), Philippe, Huot-Marchand10 (AUTHOR), Bruno, Scherrer11 (AUTHOR), Jean-Louis, Junien10 (AUTHOR), Pierre, Broqua10 (AUTHOR), Jean-Louis, Abitbol10 (AUTHOR)
Publikováno v:
Contemporary Clinical Trials. Nov2020, Vol. 98, pN.PAG-N.PAG. 1p.